<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Aqr Risk-balanced Commodities Strategy Fund Class R6 — News on 6ix</title>
<link>https://6ix.com/company/aqr-risk-balanced-commodities-strategy-fund-class-r6</link>
<description>Latest news and press releases for Aqr Risk-balanced Commodities Strategy Fund Class R6 on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 22 Apr 2026 04:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/aqr-risk-balanced-commodities-strategy-fund-class-r6" rel="self" type="application/rss+xml" />
<item>
<title>CervoMed Announces New Data at the 2026 AAN Annual Meeting that Demonstrated Neflamapimod Increased Basal Forebrain Volume and Functional Connectivity in Dementia with Lewy Bodies</title>
<link>https://6ix.com/company/aqr-risk-balanced-commodities-strategy-fund-class-r6/news/cervomed-announces-new-data-at-the-2026-aan-annual-meeting-that-demonstrated-neflamapimod-increased-basal-forebrain-volume-and-functional-connectivity-in-dementia-with-lewy-bodies</link>
<guid isPermaLink="true">https://6ix.com/company/aqr-risk-balanced-commodities-strategy-fund-class-r6/news/cervomed-announces-new-data-at-the-2026-aan-annual-meeting-that-demonstrated-neflamapimod-increased-basal-forebrain-volume-and-functional-connectivity-in-dementia-with-lewy-bodies</guid>
<pubDate>Wed, 22 Apr 2026 04:00:00 GMT</pubDate>
<description>Results consistent with pre-clinical studies demonstrating that, in the early stages of the neurodegenerative process, disease progression in the basal</description>
</item>
<item>
<title>Labcorp Launches FDA-Approved Companion Diagnostic to Identify Patients with Ovarian Cancer Eligible for KEYTRUDA®</title>
<link>https://6ix.com/company/aqr-risk-balanced-commodities-strategy-fund-class-r6/news/labcorp-launches-fda-approved-companion-diagnostic-to-identify-patients-with-ovarian-cancer-eligible-for-keytrudar-1</link>
<guid isPermaLink="true">https://6ix.com/company/aqr-risk-balanced-commodities-strategy-fund-class-r6/news/labcorp-launches-fda-approved-companion-diagnostic-to-identify-patients-with-ovarian-cancer-eligible-for-keytrudar-1</guid>
<pubDate>Wed, 22 Apr 2026 04:00:00 GMT</pubDate>
<description>BURLINGTON, N.C., April 22, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the</description>
</item>
<item>
<title>Regal Rexnord Corporation Announces Aamir Paul As Its Next Chief Executive Officer</title>
<link>https://6ix.com/company/aqr-risk-balanced-commodities-strategy-fund-class-r6/news/regal-rexnord-corporation-announces-aamir-paul-as-its-next-chief-executive-officer-2</link>
<guid isPermaLink="true">https://6ix.com/company/aqr-risk-balanced-commodities-strategy-fund-class-r6/news/regal-rexnord-corporation-announces-aamir-paul-as-its-next-chief-executive-officer-2</guid>
<pubDate>Wed, 22 Apr 2026 04:00:00 GMT</pubDate>
<description>MILWAUKEE, April 22, 2026 /PRNewswire/ -- Regal Rexnord Corporation (NYSE: RRX) announced today that its Board of Directors has appointed Aamir Paul to serve</description>
</item>
<item>
<title>Amaze Announces Launch of Amaze Live as Its Next-Generation Multi-Channel Live Shopping Platform</title>
<link>https://6ix.com/company/aqr-risk-balanced-commodities-strategy-fund-class-r6/news/amaze-announces-launch-of-amaze-live-as-its-next-generation-multi-channel-live-shopping-platform-2</link>
<guid isPermaLink="true">https://6ix.com/company/aqr-risk-balanced-commodities-strategy-fund-class-r6/news/amaze-announces-launch-of-amaze-live-as-its-next-generation-multi-channel-live-shopping-platform-2</guid>
<pubDate>Wed, 22 Apr 2026 04:00:00 GMT</pubDate>
<description>Amaze Live Enables Creators and Brands to Sell Live Across Any Channel, Without Being Locked Into a Single Platform NEWPORT BEACH, Calif., April 22, 2026</description>
</item>
</channel>
</rss>